Debut Biotechnology, Inc

Aethlon Medical is the developer of the Hemopurifier, a first-in-class medical device to treat infectious disease. The Hemopurifier addresses the largest opportunity in infectious disease, the treatment of drug and vaccine resistant viruses. The Hemourifier is a novel multi-patented platform technology designed for the single use removal of viral pathogens from blood. Regulatory and commercialization initiatives in the United States are focused on bioterror threats, while international initiatives are directed towards naturally evolving pandemic threats, and chronic infectious disease conditions including Hepatitis-C (HCV) and the Human Immunodeficiency Virus (HIV). Aethlon Medical is located in San Diego.

Angiocrine Bioscience Inc is a San Diego-based biotechnology company specializing in the development of innovative therapies for various medical conditions. With a team of experienced executives, scientists, and advisors, the company is dedicated to advancing scientific research and translating it into practical solutions that can improve patient outcomes. Through their cutting-edge science and robust pipeline, Angiocrine Bioscience aims to address unmet medical needs and revolutionize the field of regenerative medicine. Their commitment to innovation and collaboration positions them as a leading player in the biotech industry.Generated from the website

Vaxiion Therapeutics Inc is a San Diego-based biotechnology company specializing in the development of novel targeted solutions for various diseases. With a focus on innovative technology and a robust pipeline, Vaxiion Therapeutics aims to revolutionize the field of therapeutics through its rBMC platform and cutting-edge research.Generated from the website